We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+14.5%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$59B
AUM Growth
+$9.67B
Cap. Flow
+$3.02B
Cap. Flow %
5.11%
Top 10 Hldgs %
26.45%
Holding
2,790
New
663
Increased
538
Reduced
776
Closed
680

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$905M
2
NVDA icon
NVIDIA
NVDA
+$592M
3
AMD icon
Advanced Micro Devices
AMD
+$439M
4
AMGN icon
Amgen
AMGN
+$385M
5
ADBE icon
Adobe
ADBE
+$382M

Sector Composition

Rank Sector Weight
1 Technology 14.79%
2 Consumer Discretionary 13.23%
3 Healthcare 12.61%
4 Financials 7.44%
5 Communication Services 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ASTH icon
1151
Astrana Health
ASTH
$1.89B
$2.23M ﹤0.01%
58,189
+33,906
+140% +$1.13M
MSA icon
1152
Mine Safety
MSA
$6.78B
$2.23M ﹤0.01%
13,199
+8,761
+197% +$1.42M
CSWC icon
1153
Capital Southwest
CSWC
$1.46B
$2.22M ﹤0.01%
+93,744
New +$2.09M
AVPTW
1154
CALL
DELISTED
AvePoint Inc Warrant
AVPTW
$2.22M ﹤0.01%
270,000
-10,000
-4% -$12.4K
CBRL icon
1155
Cracker Barrel
CBRL
$1.17B
$2.21M ﹤0.01%
+28,727
New +$2.06M
HCVIW
1156
CALL
DELISTED
Hennessy Capital Investment Corp. VI Warrant
HCVIW
$2.21M ﹤0.01%
212,006
FCFS icon
1157
FirstCash
FCFS
$9.06B
$2.21M ﹤0.01%
+20,400
New +$2.21M
MC icon
1158
Moelis & Co
MC
$5.04B
$2.2M ﹤0.01%
+39,135
New +$1.84M
AMX icon
1159
America Movil
AMX
$77.1B
$2.19M ﹤0.01%
118,141
-210,589
-64% -$3.7M
GRNT icon
1160
Granite Ridge Resources
GRNT
$603M
$2.18M ﹤0.01%
362,938
-271,324
-43% -$1.66M
AVDL
1161
DELISTED
Avadel Pharmaceuticals
AVDL
$2.18M ﹤0.01%
154,585
-306,218
-66% -$3.6M
ASBPW
1162
CALL
Aspire Biopharma Warrant
ASBPW
$579K
$2.18M ﹤0.01%
199,998
SEE
1163
DELISTED
Sealed Air
SEE
$2.17M ﹤0.01%
59,500
+8,010
+16% +$263K
BYNOW
1164
CALL
DELISTED
byNordic Acquisition Corporation Warrant
BYNOW
$2.17M ﹤0.01%
195,362
-15,000
-7% -$917
UTHR icon
1165
United Therapeutics
UTHR
$26.3B
$2.17M ﹤0.01%
9,855
+7,407
+303% +$1.71M
AMODW
1166
CALL
Alpha Modus Holdings Warrant
AMODW
$256K
$2.16M ﹤0.01%
201,275
CAT icon
1167
Caterpillar
CAT
$402B
$2.16M ﹤0.01%
7,292
+3,993
+121% +$1.04M
SII
1168
Sprott
SII
$2.7B
$2.15M ﹤0.01%
63,373
+10,103
+19% +$312K
DEO icon
1169
Diageo
DEO
$47.3B
$2.15M ﹤0.01%
+14,740
New +$2.18M
MA icon
1170
PUT
Mastercard
MA
$487B
$2.13M ﹤0.01%
5,000
+4,900
+4,900% +$1.97M
BLEUW
1171
CALL
DELISTED
bleuacacia ltd Warrants
BLEUW
$2.13M ﹤0.01%
200,000
DMYY
1172
DELISTED
dMY Squared
DMYY
$2.13M ﹤0.01%
200,698
SLP icon
1173
Simulations Plus
SLP
$371M
$2.11M ﹤0.01%
47,213
-47,282
-50% -$1.87M
WULF icon
1174
TeraWulf
WULF
$8.91B
$2.11M ﹤0.01%
878,325
+294,025
+50% +$401K
ABG icon
1175
Asbury Automotive
ABG
$4.22B
$2.1M ﹤0.01%
+9,334
New +$1.97M

Similar funds

Marshall Wace's Q4 2023 Portfolio in Review

As of Q4 2023, Marshall Wace held 2,790 positions worth $59B, up 20% from $49.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Marshall Wace deployed $3.02B of net new capital in Q4 2023, opening 663 new positions and adding to 538 existing holdings. Its largest new stake was Qualcomm: 1,674,985 shares worth $242M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 20% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Microsoft, an estimated $905M trimmed.

  • Marshall Wace's largest Q4 2023 buy was Qualcomm: 1,674,985 shares worth $242M.
  • Marshall Wace added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $3.43B increase.
  • Marshall Wace's biggest Q4 2023 reduction was Microsoft, cutting an estimated $905M.
  • Marshall Wace fully exited VMware, Inc in Q4 2023, selling an estimated $149M.
  • Marshall Wace's ten largest holdings make up 26% of its $59B portfolio in Q4 2023.
  • Marshall Wace opened 663 new positions and closed 680 in Q4 2023.
  • Marshall Wace's portfolio value rose 20% quarter-over-quarter to $59B.

Based on Marshall Wace's 13F filing for Q4 2023, filed 14 Feb 2024.